Device Trial Radar · NCT06710626
Control of Assistive Devices Via Brain-Computer Interface Technology
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
3
Planned (sponsor's estimate)
Start
Nov 25, 2024
Primary completion
May 25, 2031
Study completion May 25, 2031
Sponsor
- Lead sponsor
- Neuralink CorpNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 29, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.
Conditions
- Tetraplegia/Tetraparesis
- Amyotrophic Lateral Sclerosis (ALS)
- Quadriplegia
- Spinal Cord Injury (SCI)
- Spinal Cord Injury Cervical
Interventions
Assistive Robotic ArmDevice
The intervention involves using the N1 Implant, a wireless brain-computer interface (BCI), to enable participants to control the Assistive Robotic Arm through neural signals.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ability of participants to modulate brain activity for controlling an assistive device via the N1 Implant.Time frame: 3-months following first use of the assistive device
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.